| Autor: |
Sankalp P. Patel, Brian J. Solomon, Robert D. Pascotto, Stephen E. D'Orazio, Elsy V. Navas, Robert J. Cubeddu, Gaston A. Cudemus |
| Rok vydání: |
2022 |
| Předmět: |
|
| Zdroj: |
Journal of cardiothoracic and vascular anesthesia. 36(8 Pt) |
| ISSN: |
1532-8422 |
| Popis: |
Often labeled the forgotten ventricle, the right ventricle's (RV) importance has been magnified over the last 2 years as providers witnessed how severe acute respiratory syndrome coronavirus 2 infection has a predilection for exacerbating RV failure. Venovenous extracorporeal membranous oxygenation (VV-ECMO) has become a mainstay treatment modality for a select patient population suffering from severe COVID-19 acute respiratory distress syndrome. Concomitant early implementation of a right ventricular assist device with ECMO (RVAD-ECMO) may confer benefit in patient outcomes. The underlying mechanism of RV failure in COVID-19 has a multifactorial etiopathogenesis; nonetheless, clinical evaluation of a patient necessitating RV support remains unchanged. Herein, the authors report the case of a critically ill patient who was transitioned from a conventional VV-ECMO Medtronic Crescent cannula to RVAD-ECMO, with the insertion of the LivaNova ProtekDuo dual-lumen RVAD cannula. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect